{"schema_version":"secwatch.filing_event.v1","accession":"0001013762-25-000999","form_type":"8-K","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2025-03-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.850923+00:00","generated_at":"2026-05-24T08:39:34.630374+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Adial Pharmaceuticals appoints Tony Goodman as COO with $300K base salary, three-year term","bullets":["Tony Goodman appointed Chief Operating Officer effective April 1, 2025, under three-year employment agreement.","Base salary of $300,000 per year; eligible for discretionary bonus up to 30% of base.","Severance: six months for without-cause termination; 12 months if termination follows a change of control.","Goodman had been serving as COO since January 2024 via consulting agreement with The Keswick Group; that agreement terminates."],"urls":{"canonical":"https://secwatch.observer/filing/0001013762-25-000999","json":"https://secwatch.observer/filing/0001013762-25-000999.json","markdown":"https://secwatch.observer/filing/0001013762-25-000999.md","text":"https://secwatch.observer/filing/0001013762-25-000999.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000101376225000999/0001013762-25-000999-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000101376225000999/ea0235166-8k_adial.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T08:39:34.630374+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5b5327fbe3","claim":"Tony Goodman was appointed as Chief Operating Officer at ADIAL PHARMACEUTICALS, INC..","evidence_excerpt":"On March 20, 2025, Adial Pharmaceuticals, Inc. (the “Company”) entered into an employment agreement with Tony Goodman (the “Goodman Employment Agreement”) to employ Mr. Goodman as the Company’s Chief Operating Officer for a three-year term effective April 1, 2025 (the “Effective Date”)","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1513525/000101376225000999/0001013762-25-000999-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}